MSCA Doctoral Network ORGESTRA: Advancing Organoid Technologies Through Joint Doctoral Training
Advancing organoid technologies for disease modelling, drug discovery and development for rare diseases
ORGESTRA is a Marie Skłodowska-Curie Joint Doctorate Network training 13 PhD candidates to conduct advanced research that addresses critical challenges in the field of organoid technologies for disease modelling, drug discovery and development for rare diseases.
This ambitious joint-PhD program provides interdisciplinary and international training across 14 partners in 7 European countries. Candidates benefit from a collaborative environment that brings together experts in molecular biology, engineering, pharmacology, clinical research, epidemiology, and ethics.
iBET’s Participation at ORGESTRA
iBET is a Host Institution for one of the Doctoral Projects focused on “Upscaling and standardisation of organoids culturing”. This project aims to develop a scalable and cGMP compatible process to generate kidney organoids and tubuloids, using 3D cell culture approaches and stirred-tank bioreactor technology.
For further project details, please see https://www.orgestra.eu/phd-positions/dc-3/.
The research will be conducted at iBET’s Stem and Immune Cells Bioengineering Lab, under the supervision of Dr. Margarida Serra. iBET will also host 4 other doctoral students completing their doctoral training at other partner institutions within the network for shorter secondments.
ORGESTRA is a four-year project funded by the EC HORIZON–MSCA-2023-DN-JD Grant Agreement No 101120108, coordinated by the University of Utrecht. The project starts 1st January 2024 and will end in December 2027.
For more information on this program, please visit https://www.orgestra.eu/